Extendicare Boosts Dividend After Strong 2025 Growth, Eyes $570M Acquisition
Event summary
- Extendicare reported Q4 2025 Adjusted EBITDA up 36.4% YoY to $45.6M, driven by home health care growth and acquisitions.
- Announced a 5% dividend increase to 4.41 cents per share, marking the second consecutive year of dividend growth.
- Agreed to acquire CBI Home Health for $570M, subject to regulatory approval, to strengthen its national leadership in home health care.
- Completed a $191.5M private placement to partially fund the CBI Home Health acquisition.
- Home health care average daily volume increased 27.3% YoY, including contributions from the Closing the Gap acquisition.
The big picture
Extendicare's strong 2025 performance and strategic acquisitions reflect the growing demand for home health care services in Canada. The $570M CBI Home Health deal positions the company to capitalize on this trend, but regulatory hurdles and integration risks remain. The dividend increase underscores confidence in sustained cash flow, but investors will watch how the company manages its balance sheet amid expansion.
What we're watching
- Regulatory Approval
- Whether Extendicare can secure necessary approvals for the CBI Home Health acquisition by Q2 2026.
- Integration Challenges
- The pace at which Extendicare can realize $7.4M in annualized synergies from the CBI Home Health acquisition.
- Dividend Sustainability
- How Extendicare will balance dividend growth with its aggressive acquisition strategy and debt financing.
Related topics